This article is more than 5 years old. Information may no longer be current.

Alphaeon to acquire Clarion

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alphaeon will acquire all outstanding shares and assets of Clarion Medical Technologies, according to an Alphaeon press release.

The amount of the acquisition was undisclosed. The deal is expected to close on or before Sept. 30, according to the release.

 “This acquisition expands Alphaeon’s geographic reach and provides early market experience with leading products from around the world, including Teoxane’s full line of dermal fillers, a strong energy device platform and multiple ophthalmic technologies that provide patients optimal outcomes,” Robert E. Grant, CEO of Alphaeon, said in the release. “We also intend to launch ShoutMD as well as our portfolio of performance, wellness and beauty products in Canada through our unique digital selling approach. We look forward to partnering closely with the specialty physicians in Canada to advance patient outcomes and experiences.”